期刊文献+

Annexin A5表达与鼻咽癌分化转移的关系 被引量:4

Relationship between Expression of Annexin A5 and Differentiation and Metastasis of Nasopharyngeal Carcinoma
下载PDF
导出
摘要 目的探讨Annexin A5表达与鼻咽癌分化和转移的关系。方法采用免疫组织化学方法检测65例鼻咽癌、18例淋巴结转移性鼻咽癌和20例慢性鼻炎标本中Annexin A5的表达水平,并分析其表达水平与鼻咽癌临床病理特征的关系;采用Western blot检测不同分化程度和不同转移潜能NPC细胞系中Annexin A5的表达;采用siRNA技术下调5-8F细胞中Annexin A5表达后,观察其侵袭能力的变化。结果 Annexin A5的阳性表达率在鼻咽癌、淋巴结转移鼻咽癌和对照组中分别为84.6%(55/65)、94.4%(17/18)和10.0%(2/20);淋巴结转移性鼻咽癌组高于鼻咽癌组,鼻咽癌组高于对照组,差异有统计学意义(P<0.05)。Annexin A5表达与组织学类型、局部转移、淋巴结转移、远处转移、临床分期和复发有关(P<0.05),而与年龄,性别无关。Annexin A5表达下调能降低NPC细胞的侵袭能力。结论 Annexin A5表达与鼻咽癌的分化和转移有关,可作为NPC分化、转移及预后的分子标志物。 Objective To study the relationship between expression of Annexin A5 and the differentiation and metastasis of nasopharyngeal carcinoma(NPC).Methods The expression of Annexin A5 in specimens of 65 of NPC,18 of lymph node metastasizing NPC(LMNPC) and 20 of chronic rhinitis(CR) were detected by immunohistochemistry.The correlation between the expression of Annexin A5 and clinic factors was analyzed.The expression of Annexin A5 in NPC cell lines with differential differentiation degree and metastasis potency was detected by Western blot.Observe the change of invasive capability of NPC cells after the downregulation of Annexin A5 by siRNA.Results The positive ratio of Annexin A5 in NPC,LMNPC and CR were 84.6%(55/65),94.4%(17/18) and 10.0%(2/20),respectively.There were significant difference in the expression of Annexin A5 between NPC and LMNPC,NPC and CR(P0.05).There were correlation among the expression of Annexin A5 and histological type,regional meastasis,distant metastasis,clinic stage and recurrence(P0.05).And was no relationship with ages and gender.There was relationship among expression of Annexin A5 and differentiation and metastasis of NPC.Downregulation of Annexin A5 can decrease the invasive capability of 5-8F cells.Conclusion There was relationship among the expression of Annexin A5 and the differentiation and metastasis of NPC,and could serve as a biomarker of differentiation,metastasis and prognosis in NPC.
作者 李岭 庄英帜
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第4期389-393,共5页 Cancer Research on Prevention and Treatment
关键词 鼻咽癌 膜联蛋白5 分化 转移 分子标志物 Nasopharyngeal carcinoma Annexin A5 Differentiation Metastasis Biomarker
  • 相关文献

参考文献21

  • 1Yu MC, Yuan JM.Epidemiology of nasopharyngeal carcinoma [J].Semin Cancer Biol,2002, 12(6):421-429.
  • 2Ho HC, Lee MS, Hsiao SH, et al.Prognostic influence of parapharyngeal extension in nasopharyngeal carcinoma [J].Acta Otolaryngol,2008, 128(7):790-798.
  • 3Agulnik M, Siu LL.State-of-the-art management of nasopharyngeal carcinoma: current and future directions [J].Br J Cancer,2005, 92(5):799-806.
  • 4张文玲,周艳宏,肖岚,范松青,曾朝阳,李小玲,武明花,李桂源.鼻咽癌分子标志物研究[J].生物化学与生物物理进展,2008,35(1):7-13. 被引量:32
  • 5Mussunoor S, Murray GI.The role of annexins in tumour development and progression [J] .J Pathol,2008, 216(2):131-140.
  • 6Mortimer JC, Laohavisit A, Macpherson N, et al.Annexins: multifunctional components of growth and adaptation [J].J Exp Bot,2008, 59(3):533-544.
  • 7Lampl Y, Lorberboym M, Blankenberg FG, et al.Annexin V SPECT imaging of phosphatidylserine expression in patients with dementia [J].Neurology,2006, 66(8):1253-1254.
  • 8van Tits L, de Graaf J, Toenhake H, et al.C-reactive protein and annexin A5 bind to distinct sites of negatively charged phospholipids present in oxidized low-density lipoprotein [J].Arterioscler Thromb Vasc Biol,2005, 25(4):717-722.
  • 9Rand JH, Wu XX, Quinn AS, et al.Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug [J].Blood,2010, 115(11):2292-2299.
  • 10Rand JH, Wu XX, Quinn AS, et al.Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome [J].Lupus,2008, 17(10):922-930.

二级参考文献41

  • 1Benz J,Hofmann A.Annexins:from structure to function.Biol Chem,1997,378(3-4):177-183.
  • 2Dubois T,Oudinet JP,Mira JP,et al.Annexins and protein kinases C.Biochim Biophys Acta,1996,1313(3):290-294.
  • 3Cookson BT,Engelhardt S,Smith C,et al.Organization of the human annexin V (ANX5) gene.Genomics,1994,20(3):463-467.
  • 4Reutelingsperger CP,van Heerde,Annexin V.The regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis.Cell Mol Life Sci,1997,53(6):527-532.
  • 5Dumont EA,Hofstra L,van Heerde WL,et al.Cardiomyocyte death induced by myocardial ischemia and reperfusion:measurement with recombinant human annexin-V in a mouse model.Circulation,2000,102(13):1564-1568.
  • 6Akiairo K,Yoshuiiro MD,Kiyosh MD,et al.Suppression of calphobidin I (CPB I) production in carcinoma of uterine cervix and endometrium.Gynecol Oncol,1995,58(3):295-300.
  • 7Carole GJ,Egle S,Andre as H,et al.Annexin V counteracts apoptosis while inducing Ca^2+ influx in human lymphocytic T cells.Biochem Biophys Res Commun,1999,265(3):709-715.
  • 8Timothy EH,Debipriya D,Barry Y,et al.DT40 cells lacking the Ca^2+-binding protein annexin 5 are resistant to Ca^2+-dependent apoptosis.PNAS,2002,99 (12):8054-8059.
  • 9Virginie M,Yulia B,Gueorgui K,et al.Externalization of endogenous annexin A5 participates in apoptosis of rat cardiomyocytes.Cardiovasc Res,2004,64(3):496-506.
  • 10Fan S Q,Ma J,Zhou J,et al.Defferential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis.Hum Pathol,2006,37:593 -605

共引文献35

同被引文献43

  • 1张红茹,肖健云,赵素萍,唐瑶云,李萃,冯雪萍.喉癌及喉正常黏膜组织蛋白质组差异表达的初步研究[J].中国耳鼻咽喉颅底外科杂志,2004,10(3):136-139. 被引量:8
  • 2李翠联,陈世伦,陈文明,刘敬忠,肖白,张海波.三氧化二砷改变多发性骨髓瘤细胞基因表达的研究[J].中华血液学杂志,2005,26(4):209-213. 被引量:6
  • 3田勇泉,孙爱华.耳鼻咽喉头颈外科学[M].北京:人民卫生出版社,2005:172.
  • 4Ewing MM, De vile MR, Nordzell M, et al. Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in mice [ J ]. Arterioscler Thromb Vasc Biol, 2011, 31(1) : 95 - 101.
  • 5Sater MS, Finan RR, Mustafa FE, et al. Anti-annexin V IgM and IgG autoantibodies and the risk of idiopathic recur- rent spontaneous miscarriage [ J ] . Reprod Immunol, 2011 , 89(1) :78 -83.
  • 6Rand JH, Wu XX, Quinn AS, et al. Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies:evidence for a novel effect for an old antimalarial drug [J]. Blood, 2010, 115(11) : 2292 -2299.
  • 7Kheifets V, Bright R, Inagaki K, et al. Protein kinase C delta (deitaPKC)-annexin V interaction: a required step in deltaPKC translocation and function [ J ]. Biol Chem, 2006, 281(32): 23218-23226.
  • 8Xue G, Hao LQ, Ding FX, et al. Expression of annexin A5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas [ J ]. Clin Gastroenterol, 2009, 43(9) : 831 -837.
  • 9Wehder L, Arndt S, Murzik U, et al. Annexin A5 is in- volved in migration and invasion of oral carcinoma [ J ]. Cell Cycle, 2009, 8(10): 1552- 1558.
  • 10Deng S, Wang J, Hou L, et al. Annexin A1, A2, A4 andA5 play important roles in breast cancer, pancreatic cancer and laryngeal carcinoma, alone and/or synergistically [J]. Oncol Lett, 2013, 5(1):107-112.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部